The Pharma industry is up 4.1% in the last week, with Neuren Pharmaceuticals up 10%. During this same period, the Mayne Pharma Group underperformed, falling 19%. This takes the industry's 12 month performance to a gain of 50%. Looking forward, earnings are forecast to grow by 23% annually.
Has the Australian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 22 May 2024 | AU$6.1b | AU$1.2b | -AU$374,923,684.00 | 13.1x | -16.3x | 5x |
Fri, 19 Apr 2024 | AU$5.6b | AU$1.2b | -AU$374,923,684.00 | 14.8x | -15x | 4.6x |
Sun, 17 Mar 2024 | AU$5.5b | AU$1.2b | -AU$374,923,684.00 | 14.6x | -14.8x | 4.6x |
Tue, 13 Feb 2024 | AU$5.7b | AU$892.7m | -AU$536,464,511.00 | 20.5x | -10.6x | 6.4x |
Thu, 11 Jan 2024 | AU$5.7b | AU$896.3m | -AU$589,604,392.00 | 21.2x | -9.6x | 6.3x |
Sat, 09 Dec 2023 | AU$4.3b | AU$896.3m | -AU$589,604,392.00 | 16.7x | -7.4x | 4.8x |
Mon, 06 Nov 2023 | AU$3.7b | AU$893.0m | -AU$595,020,018.00 | 18.5x | -6.2x | 4.1x |
Wed, 04 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 19.4x | -6x | 3.9x |
Fri, 01 Sep 2023 | AU$4.0b | AU$1.1b | -AU$597,354,809.00 | 19.8x | -6.7x | 3.6x |
Sun, 30 Jul 2023 | AU$4.2b | AU$999.0m | -AU$624,794,303.00 | 22.4x | -6.8x | 4.2x |
Tue, 27 Jun 2023 | AU$3.9b | AU$999.0m | -AU$624,794,303.00 | 21.1x | -6.2x | 3.9x |
Thu, 25 May 2023 | AU$4.0b | AU$993.2m | -AU$640,306,659.00 | 17.8x | -6.3x | 4.1x |
Sat, 22 Apr 2023 | AU$4.2b | AU$993.2m | -AU$641,969,868.00 | 18.2x | -6.6x | 4.3x |
Mon, 20 Mar 2023 | AU$4.1b | AU$995.9m | -AU$648,651,745.00 | 18.7x | -6.3x | 4.1x |
Wed, 15 Feb 2023 | AU$3.6b | AU$980.5m | -AU$579,761,791.00 | 17.2x | -6.3x | 3.7x |
Fri, 13 Jan 2023 | AU$4.2b | AU$948.3m | -AU$544,428,006.00 | 13.2x | -7.7x | 4.4x |
Sun, 11 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,005.00 | 13.1x | -7.1x | 4.1x |
Tue, 08 Nov 2022 | AU$4.2b | AU$948.3m | -AU$544,428,005.00 | 12.9x | -7.8x | 4.5x |
Thu, 06 Oct 2022 | AU$4.2b | AU$946.2m | -AU$548,400,005.00 | 12x | -7.6x | 4.4x |
Sat, 03 Sep 2022 | AU$4.0b | AU$943.3m | -AU$537,548,829.00 | 12.8x | -7.4x | 4.2x |
Mon, 01 Aug 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 15.3x | -11.1x | 4.8x |
Wed, 29 Jun 2022 | AU$3.2b | AU$818.2m | -AU$353,932,589.00 | 12.3x | -9.1x | 4x |
Fri, 27 May 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 15x | -11.1x | 4.8x |
Sun, 24 Apr 2022 | AU$4.2b | AU$800.9m | -AU$348,637,558.00 | 16.2x | -12x | 5.2x |
Tue, 22 Mar 2022 | AU$4.4b | AU$799.2m | -AU$341,805,125.00 | 17.4x | -12.9x | 5.5x |
Thu, 17 Feb 2022 | AU$4.7b | AU$749.0m | -AU$464,190,190.00 | 20.7x | -10x | 6.2x |
Sat, 15 Jan 2022 | AU$5.0b | AU$758.4m | -AU$450,516,414.00 | 21.3x | -11.1x | 6.6x |
Mon, 13 Dec 2021 | AU$4.9b | AU$758.4m | -AU$450,516,414.00 | 25.2x | -10.8x | 6.4x |
Wed, 10 Nov 2021 | AU$5.0b | AU$758.4m | -AU$447,307,205.00 | 23.7x | -11.1x | 6.5x |
Fri, 08 Oct 2021 | AU$4.7b | AU$753.7m | -AU$446,965,453.00 | 23.6x | -10.6x | 6.3x |
Sun, 05 Sep 2021 | AU$4.9b | AU$756.0m | -AU$452,225,384.00 | 22x | -10.8x | 6.4x |
Tue, 03 Aug 2021 | AU$4.1b | AU$752.8m | -AU$442,004,016.00 | 20.8x | -9.3x | 5.5x |
-9.9x
How does Australian Pharma compare with similar industries?
AU Market | 1.47% | |
Healthcare | -1.42% | |
Pharma | 0.94% | |
Pharma | 0.94% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
CU6 Clarity Pharmaceuticals | AU$4.07 | 6.0% +AU$71.5m | 439.1% | PS133.4x | |
BOT Botanix Pharmaceuticals | AU$0.28 | 9.8% +AU$39.4m | 201.1% | PS1008.7x | |
LTP LTR Pharma | AU$0.50 | 49.3% +AU$23.0m | n/a | n/a | |
AGN Argenica Therapeutics | AU$0.73 | 2.8% +AU$2.5m | 82.5% | PS32.9x | |
EOF Ecofibre | AU$0.058 | 9.4% +AU$1.8m | -70.3% | PS0.7x |